$ARRT
Artisan Consumer Goods, Inc.

2024 Q2 Form 10-Q Financial Statement

#000147793224002796 Filed on May 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $0.00 $0.00 $11.00
YoY Change -100.0%
Cost Of Revenue $0.00 $0.00 $3.635K
YoY Change -100.0%
Gross Profit $0.00 $0.00 -$3.624K
YoY Change -100.0%
Gross Profit Margin -32945.45%
Selling, General & Admin $3.120K $7.040K $7.690K
YoY Change -8.45% 127.51%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $750.00 $750.00 $750.00
YoY Change 0.0% 0.0%
% of Gross Profit
Operating Expenses $3.870K $7.791K $8.436K
YoY Change -7.65% 104.41%
Operating Profit -$3.870K -$7.791K -$12.06K
YoY Change -35.4% 192.22%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.690K $214.00 $21.00
YoY Change 919.05% -86.0%
Pretax Income $9.070K -$7.580K -$12.04K
YoY Change -37.04% 202.51%
Income Tax
% Of Pretax Income
Net Earnings $9.070K -$7.577K -$12.04K
YoY Change -37.06% 202.72%
Net Earnings / Revenue -109445.45%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 4.400M shares 4.400M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.800K $80.00 $2.160K
YoY Change -96.3% -87.25%
Cash & Equivalents $1.795K $79.00 $2.157K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $0.00 $0.00 $0.00
Prepaid Expenses
Receivables $833.00
Other Receivables $0.00
Total Short-Term Assets $1.795K $79.00 $2.990K
YoY Change -13.16% -97.36% -82.35%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $1.000K $1.000K $1.000K
YoY Change 0.0% 0.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.125K $1.875K $4.875K
YoY Change -72.73% -61.54% -38.13%
TOTAL ASSETS
Total Short-Term Assets $1.795K $79.00 $2.990K
Total Long-Term Assets $1.125K $1.875K $4.875K
Total Assets $2.920K $1.954K $7.865K
YoY Change -52.84% -75.16% -68.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $33.69K $50.32K $49.97K
YoY Change -31.96% 0.7% 69.15%
Accrued Expenses $46.36K $48.04K $48.25K
YoY Change -3.94% -0.43% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $200.7K $190.7K $165.7K
YoY Change 15.09% 7.42%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $280.7K $289.0K $263.9K
YoY Change 5.36% 9.53% 13.74%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $280.7K $289.0K $263.9K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $280.7K $289.0K $263.9K
YoY Change 9.53% 13.74%
SHAREHOLDERS EQUITY
Retained Earnings -$19.28M -$19.29M -$19.25M
YoY Change 0.1% 0.17% 0.26%
Common Stock $4.400K $0.00 $4.400K
YoY Change 0.0% -100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$277.8K -$287.1K -$256.0K
YoY Change
Total Liabilities & Shareholders Equity $2.920K $1.954K $7.865K
YoY Change -52.84% -75.16% -68.31%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $9.070K -$7.577K -$12.04K
YoY Change -37.06% 202.72%
Depreciation, Depletion And Amortization $750.00 $750.00 $750.00
YoY Change 0.0% 0.0%
Cash From Operating Activities -$8.280K -$5.920K -$6.700K
YoY Change -11.64% 115.43%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.00K 6.000K 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -8.280K -5.920K -6.700K
Cash From Investing Activities 0.000
Cash From Financing Activities 10.00K 6.000K 0.000
Net Change In Cash 1.720K 80.00 -6.700K
YoY Change -101.19% 115.43%
FREE CASH FLOW
Cash From Operating Activities -$8.280K -$5.920K -$6.700K
Capital Expenditures $0.00
Free Cash Flow -$6.700K
YoY Change 115.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
350 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
315 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The Company provides estimates for its common stock valuations and valuation allowances for deferred taxes.</p>
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
214 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001530425
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4400048 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4400048 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4400048 shares
CY2023Q2 us-gaap Inventory Net
InventoryNet
0 usd
CY2023Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
750 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54838
dei Entity Registrant Name
EntityRegistrantName
ARTISAN CONSUMER GOODS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1240056
dei Entity Address Address Line1
EntityAddressAddressLine1
999 N Northlake Way Ste 203
dei Entity Address City Or Town
EntityAddressCityOrTown
Seattle
dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98103-3442
dei City Area Code
CityAreaCode
206
dei Local Phone Number
LocalPhoneNumber
517-7147
dei Security12b Title
Security12bTitle
Common
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Trading Symbol
TradingSymbol
ARRT
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4400048 shares
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2067 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
79 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
2067 usd
CY2024Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
875 usd
CY2023Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
3125 usd
CY2024Q1 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
1000 usd
CY2023Q2 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
1000 usd
CY2024Q1 us-gaap Other Assets
OtherAssets
1875 usd
CY2023Q2 us-gaap Other Assets
OtherAssets
4125 usd
CY2024Q1 us-gaap Assets
Assets
1954 usd
CY2023Q2 us-gaap Assets
Assets
6192 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
50318 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
49522 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
48043 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
48257 usd
CY2024Q1 arrt Due To Related Party Current
DueToRelatedPartyCurrent
190666 usd
CY2023Q2 arrt Due To Related Party Current
DueToRelatedPartyCurrent
168666 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
289027 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
266445 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2024Q1 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
4400 usd
CY2023Q2 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
4400 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18984200 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18984200 usd
CY2024Q1 arrt Stock Shares Subscribed But Unissued Value
StockSharesSubscribedButUnissuedValue
10553 usd
CY2023Q2 arrt Stock Shares Subscribed But Unissued Value
StockSharesSubscribedButUnissuedValue
9398 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19286226 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19258251 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-287073 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-260253 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1954 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6192 usd
CY2024Q1 us-gaap Revenues
Revenues
0 usd
CY2023Q1 us-gaap Revenues
Revenues
11 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
7445 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
3635 usd
us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
9400 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
0 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
-3624 usd
us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
-1955 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
350 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
315 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1155 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1645 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
5324 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
6768 usd
us-gaap Professional Fees
ProfessionalFees
21715 usd
us-gaap Professional Fees
ProfessionalFees
23899 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1367 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
603 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3069 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8668 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
750 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
750 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2250 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2250 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
7791 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
8436 usd
us-gaap Operating Expenses
OperatingExpenses
28189 usd
us-gaap Operating Expenses
OperatingExpenses
36462 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7791 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-12060 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-28189 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-38417 usd
CY2024Q1 us-gaap Other Income
OtherIncome
214 usd
CY2023Q1 us-gaap Other Income
OtherIncome
21 usd
us-gaap Other Income
OtherIncome
214 usd
us-gaap Other Income
OtherIncome
36 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
214 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
21 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
214 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
36 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-7577 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-12039 usd
us-gaap Net Income Loss
NetIncomeLoss
-27975 usd
us-gaap Net Income Loss
NetIncomeLoss
-38381 usd
CY2024Q1 arrt Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.00
CY2023Q1 arrt Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.00
arrt Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.01
arrt Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.01
CY2024Q1 arrt Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
4400048 shares
CY2023Q1 arrt Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
4400048 shares
arrt Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
4400048 shares
arrt Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
4400048 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-244295 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
315 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-12039 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-256019 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-219283 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1645 usd
us-gaap Net Income Loss
NetIncomeLoss
-38381 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-256019 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-279846 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
350 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-7577 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-287073 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-260253 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1155 usd
us-gaap Net Income Loss
NetIncomeLoss
-27975 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-287073 usd
us-gaap Net Income Loss
NetIncomeLoss
-27975 usd
us-gaap Net Income Loss
NetIncomeLoss
-38381 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
2250 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
2250 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1155 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1645 usd
us-gaap Equity Fair Value Adjustment
EquityFairValueAdjustment
214 usd
us-gaap Equity Fair Value Adjustment
EquityFairValueAdjustment
36 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-833 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8224 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
796 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5717 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23988 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32848 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
22000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
21450 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21450 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1988 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-11398 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2067 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13555 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2157 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
750 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
21 usd

Files In Submission

Name View Source Status
0001477932-24-002796-index-headers.html Edgar Link pending
0001477932-24-002796-index.html Edgar Link pending
0001477932-24-002796.txt Edgar Link pending
0001477932-24-002796-xbrl.zip Edgar Link pending
arrt-20240331.xsd Edgar Link pending
arrt_10q.htm Edgar Link pending
arrt_ex311.htm Edgar Link pending
arrt_ex312.htm Edgar Link pending
arrt_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
arrt-20240331_cal.xml Edgar Link unprocessable
arrt-20240331_def.xml Edgar Link unprocessable
arrt-20240331_lab.xml Edgar Link unprocessable
arrt_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
arrt-20240331_pre.xml Edgar Link unprocessable